Trials / Conditions / Relapsed/Refractory B-cell Lymphomas
Relapsed/Refractory B-cell Lymphomas
3 registered clinical trials studyying Relapsed/Refractory B-cell Lymphomas — 1 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Recruiting | L218CAR19 in Patients With Relapsed/Refractory B-cell Lymphoma NCT06478381 | Henan Cancer Hospital | Phase 1 |
| Completed | Long-term Follow-up Study for Patients Treated With CLBR001 CAR-T NCT04488354 | Calibr, a division of Scripps Research | Phase 1 |
| Completed | CLBR001 and SWI019 in Patients With Relapsed / Refractory B-cell Malignancies NCT04450069 | Calibr, a division of Scripps Research | Phase 1 |